Indirect Comparisons of Efficacy of Zanubrutinib Versus Orelabrutinib in Patients with R/R MCL: An Extended Follow-up Analysis
MAIC results demonstrated that zanubrutinib had significantly longer PFS compared with orelabrutinib in the treatment of patients with R/R MCL.
Authors
- Jie Jin (ORCID: https://orcid.org/0000-0002-8166-9915)
- Sheng Xu (ORCID: https://orcid.org/0000-0003-0757-8289)
- Huilai Zhang (ORCID: https://orcid.org/0000-0002-8558-3131)
- Fang Cheng (ORCID: https://orcid.org/0000-0002-8260-9244)
- Dehui Zou (ORCID: https://orcid.org/0000-0002-8135-4913)
- Dengju Li
- Jun Zhu (ORCID: https://orcid.org/0000-0003-3479-2547)
- Fangfang Lv (ORCID: https://orcid.org/0000-0001-6636-3056)
- Haiyan Yang (ORCID: https://orcid.org/0000-0001-5185-4696)
- Keshu Zhou (ORCID: https://orcid.org/0000-0001-5467-1377)
- Jianda Hu (ORCID: https://orcid.org/0000-0002-4438-2544)
- Sujun Gao (ORCID: https://orcid.org/0000-0002-1090-5802)
- Ru Feng (ORCID: https://orcid.org/0000-0001-6135-3545)
- Lijuan Deng (ORCID: https://orcid.org/0000-0001-5072-390X)
- Jie Ji (ORCID: https://orcid.org/0000-0003-4038-9180)
- Wei Xu (ORCID: https://orcid.org/0000-0002-1337-0620)
- Yuqin Song (ORCID: https://orcid.org/0000-0002-5118-0625)
Institutions
- Fujian Medical University (CN)
- Jilin University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking University (CN)
- Sichuan University (CN)
- Tianjin Medical University Cancer Institute and Hospital (CN)
- Zhengzhou University (CN)
- West China Hospital of Sichuan University (CN)
- Fudan University Shanghai Cancer Center (CN)
- Peking University Cancer Hospital (CN)
- Zhejiang Cancer Hospital (CN)
- BeiGene (China) (CN)
- Nanfang Hospital (CN)
- First Hospital of Jilin University (CN)
- Henan Cancer Hospital (CN)
- Institute of Hematology & Blood Diseases Hospital (CN)
- Jiangsu Province Hospital (CN)
- Tongji Hospital (CN)
- Union Hospital (CN)
- First Affiliated Hospital Zhejiang University (CN)
- Southern Medical University (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Advances in Therapy
- Published
- 2025-05-03
- DOI
- https://doi.org/10.1007/s12325-025-03202-x
- Primary Topic
- Chronic Lymphocytic Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- BeiGene